ãå¹ãæåãã§ãããããªãæ¬çªã¯NGããããã¢ã¹ãªãŒãã®ã«ãã§ã€ã³è©Šè¡ãããã³ã«
ã«ãã§ã€ã³ã¯ãã¹ããŒãã®äžçã§ããç¥ãããæåã§ãã
ããã§ããç§ãæåã«äŒãããã®ã¯ãã«ãã§ã€ã³ã¯å¹ãããšãã話ã ãã§ã¯ãããŸããã
ç ç©¶äžã¯æå¹æ§ãæ¯æãããšããã³ã¹ã匷ããŠããå®éã®ç«¶æçŸå Žã§ã¯ãå¹æã®æãæ¹ãå¯äœçšãéžæã«ãã£ãŠéããŸããã ããããã詊ååœæ¥ã«åããŠäœ¿ãã®ã§ã¯ãªãããã¬ãŒãã³ã°ã®äžã§èªåã«åãæ¡ä»¶ãæ¢ããæ¬çªã§åçŸã§ãããšãããŸã§æºåããå¿ èŠããããŸãã
ãã®èšäºã§ã¯ãã«ãã§ã€ã³ã«ã€ããŠç ç©¶ããèšããããšãšããããã«ããŽãªãŒéžæã®æ é€ãµããŒãçŸå Žã§æããŠããããšãåããŠæŽçããæäººéžæãæ¬çªãŸã§ã«è©Šãæé ã玹ä»ããŸãã
ã«ãã§ã€ã³ã¯ããšããã³ã¹ã匷ãæåã®äžã€
åœéã¹ããŒãæ é€åŠäŒïŒISSNïŒã®ã¬ãã¥ãŒã§ã¯ãã«ãã§ã€ã³ã¯ããã©ãŒãã³ã¹åäžæåã®ãã¡ãæå¹æ§ãæ¯æãã匷ããšããã³ã¹ããããæŠãå®å šãšèããããïŒStrong Evidence to Support Efficacy and Apparently SafeïŒãã«ããŽãªãŒã«åé¡ãããŠããŸãã
2021幎ã®ISSNããžã·ã§ã³ã¹ã¿ã³ãã§ã¯ãæä¹ æ§éåãã¯ãããçæä¹ åãã¹ããªã³ãããžã£ã³ããæãŠããæ³šæãèŠéãªã©ãããŸããŸãªå Žé¢ã§å°ãäžçšåºŠã®ã¡ãªããã瀺ãããŠããŸãããã ãããã¹ãŠã®ç ç©¶ããã¹ãŠã®äººã§æ¹åããããã§ã¯ãããŸããã
ç ç©¶ã§äžè²«ããŠå¹æã瀺ãããäžå¿çãªéã¯ãäœé1kgããã3ã6mgã§ããäžæ¹ãæå°æå¹éã¯ãŸã æç¢ºã§ã¯ãªãã2mg/kgçšåºŠã§ã广ãåºãå¯èœæ§ããããŸãã9mg/kgã®ãããªé«çšéã¯ãåãæ°ãäžå®ãèœã¡çããªããäžç çã®å¯äœçšãå¢ããããã广ãåŸãããã«å¿ èŠãšã¯èããããŠããŸããã
ã€ãŸãããšããã³ã¹ã匷ãããšãšãããããæãã°ããããšã¯å¥ã§ãã
ãããã¢ã¹ãªãŒãã«ããåãã»åããªããããã
ç§ãæ é€ãµããŒãã§é¢ãã£ããæ±äº¬2020åºå Žçµéšã®ããéžäžéžæãBãªãŒã°éžæãSVãªãŒã°éžæã®äžã«ããã«ãã§ã€ã³æååŸã«ãã©ã¹ã®äœæãå ±åããéžæãè€æ°ããŸãã
äžæ¹ã§ãå šå¡ã«åãåå¿ãåºãããã§ã¯ãããŸãããäœæãä¹ããå Žåãããã°ãåæžãèœã¡çããªããèè žã®éåæãå€ã®ç¡ç ãžã®åœ±é¿ãæ°ã«ãªãå ŽåããããŸãã
ããããçŸå Žã§ã®èгå¯ã¯ãç ç©¶çµæãã®ãã®ã§ã¯ãããŸãããå人ãç¹å®ããªãç¯å²ã§ã®çµéšã§ãããç ç©¶ã§ææãããå人差ããå®éã®ãµããŒãã§ãéèŠã ãšæããŠããŸãã
æäººéžæãæ¬çªãŸã§ã«è©Šã7ã€ã®æé
ããããã¯ãæäººç«¶æè ããµããŒãã¹ã¿ãããšçžè«ããªãã詊ãããã®å®åæ¡ã§ããç ç©¶äžã®æšæºéããæåããå šå¡ã«å§ãããã®ã§ã¯ãããŸããã
1ïŒãŸããåå°ã確èªãã
ç¡ç äžè¶³ããšãã«ã®ãŒäžè¶³ããã«ãã§ã€ã³ã§èŠãé ãããšã¯ã§ããŸãããé£äºã詊ååã®è£é£ãæ°Žåè£çµŠãç¡ç ãæŽã£ãŠããããå ã«ç¢ºèªããŸãã
ãŸããã³ãŒããŒãè¶ããšããžãŒããªã³ã¯ãã¬ã ããžã§ã«ããµããªçãåãããæ®æ®µã©ã®ãããã«ãã§ã€ã³ãæã£ãŠããããææ¡ããŸããè€æ°ã®ååãéãããšãæ³å®ä»¥äžã®éã«ãªãããšããããŸãã
2ïŒæåã¯çŽ2mg/kgãç®å®ã«æ€èšãã
æåã®ç®çã¯ãæå€§å¹æãçãããšãã§ã¯ãªããåå¿ã確èªããããšã§ããISSNã§ã¯æå°æå¹éã2mg/kgçšåºŠã§ããå¯èœæ§ã瀺ãããŠãããããæäººéžæã®å®åã§ã¯ããŸãçŽ2mg/kgãç®å®ã«æ€èšããŸãã
äŸãã°ãäœé60kgãªãçŽ120mgã70kgãªãçŽ140mgã§ããããã¯äžåŸã®åŠæ¹ã§ã¯ãªããæ¢åŸæŽãæè¬ãæ®æ®µã®æåéãç«¶ææéãç¡ç ãžã®åœ±é¿ãèžãŸããŠèª¿æŽããåºçºç¹ã§ãã
3ïŒè©Šåã«è¿ããã¬ãŒãã³ã°æ¥ã«è©Šã
éåéå§çŽ60ååã¯ãç ç©¶ã§ãã䜿ãããã¿ã€ãã³ã°ã§ãããã ããã«ãã»ã«ã飲æããžã§ã«ãã¬ã çã§ã¯åžåã®ä»æ¹ãç°ãªãããã補å圢æ ã«åãããŠèããŸãã
è©Šãæ¥ã¯ãã§ããã ã詊åã«è¿ãæé垯ãé£äºããŠã©ãŒã ã¢ãããéåå 容ã«ããŸããå€ã®è©Šåãæ³å®ããå Žåã¯ãéåäžã®æèŠã ãã§ãªãããã®å€ã®å¯ã€ããç¡ç ã®è³ªãŸã§ç¢ºèªããŸãã
4ïŒãå¹ãããã以å€ãèšé²ãã
å°ãªããšã次ãèšé²ããŸãã
䞻芳çãªéå匷床ãçµç€ã®ãã€ã
éäžããããã倿ãããã
åæžãèœã¡çããªããäžå®æ
èè žçç¶ãé ç
å¯ã€ããç¡ç æéãç¿æã®æèŠ
èšé²ããªããšãã«ãã§ã€ã³ã®åœ±é¿ãšããã®æ¥ã®äœèª¿ãé£äºãç·Žç¿å 容ã®éããåãã«ãããªããŸãã
5ïŒå¥æ¥ã«2ã3åãåçŸæ§ãèŠã
1åããã£ãã ãã§æ¬çªãžé²ããŸãããäŒŒãæ¡ä»¶ã§2ã3å詊ããåããããªåå¿ãåºããã確èªããŸããå¯èœã§ããã°ãã«ãã§ã€ã³ãæããªãæ¡ä»¶ãšãæ¯ã¹ãŸãã
广ãä¹ãããå¯äœçšãç¡ç ãžã®æªåœ±é¿ããªãå Žåã«éããå°éè·ãšçžè«ããŠçŽ3mg/kgãæ€èšããŸããæåãã6mg/kgãŸã§å¢ããå¿ èŠã¯ãããŸããã
6ïŒè£œååã ãã§ãªããããããŸã§ç¢ºèªãã
æ¥æ¬ã§è³Œå ¥ãããããã«ãã§ã€ã³éãæç¢ºã§ã補ååã»ãã¬ãŒããŒã»çŸè¡ããããŸã§ç¬¬äžè èªèšŒããŒã¿ããŒã¹ã§ç¢ºèªã§ããéžæè¢ã¯å€ããããŸããã
èªèšŒããŽãä»ããŠããŠãããã©ã³ãã®å šååã察象ãšã¯éããŸããã確èªããã®ã¯ããã©ã³ãåã ãã§ãªãã補ååããã¬ãŒããŒããããçªå·ã§ããè³Œå ¥æãšè©Šååã«èªèšŒããŒã¿ããŒã¹ã確èªããèšé²ãç»é¢ãä¿åããŠãããšç®¡çãããããªããŸãã
第äžè èªèšŒã¯ãçŠæ¢ç©è³ªæ··å ¥ã®ãªã¹ã¯ãäžããææ®µã§ããéåãèµ·ããªãããšãä¿èšŒãããã®ã§ã¯ãªããç«¶æè ã«ã¯å³æ Œè²¬ä»»ããããŸãã
ãªããã«ãã§ã€ã³èªäœã¯WADAã®çŠæ¢ç©è³ªã§ã¯ãããŸãããã2026幎ãç«¶æäŒæã®ã¢ãã¿ãªã³ã°ã»ããã°ã©ã 察象ã§ãã
7ïŒæ¬çªã§ã¯ãç¢ºèªæžã¿ã®æ¡ä»¶ã ããåçŸãã
æ¬çªã§å€ããªããã®ã¯ãã«ãã§ã€ã³éã ãã§ã¯ãããŸããã
æåããæå»
補åãšãã¬ãŒããŒ
ããã
äžç·ã«æãé£äºãæ°Žå
ãŠã©ãŒã ã¢ãããŸã§ã®æµã
ã詊åã ããå°ãå¢ããããäŒå Žã§åããŠèŠãååã䜿ãããšãã£ã倿Žã¯é¿ããŸãã
åŠçã¢ã¹ãªãŒããšã¹ããŒããããºã®ä¿è·è ãž
ãã®èšäºã®äœéæç®ãããã³ã«ã¯ãæäººç«¶æè ã察象ã«ããŠããŸãã
æªæå¹Žè ãã«ãã§ã€ã³ãµããªããšããžãŒããªã³ã¯ãèªå·±å€æã§ç«¶æå©çšããããšã¯å§ããŸããã幎霢ãäœæ Œãå¥åº·ç¶æ ãç¡ç ãæ®æ®µã®é£ç掻ãèžãŸããä¿è·è ãæå°è ãå»åž«ãç®¡çæ é€å£«çãžçžè«ããŠãã ããã
ç¹ã«æé·æã§ã¯ãããã©ãŒãã³ã¹æåãè¶³ãåã«ãæ¥ã ã®é£äºãè£é£ãæ°Žåè£çµŠãç¡ç ã®åªå é äœã確èªããããšã倧åã§ãã
ãŸãšã
ã«ãã§ã€ã³ã¯ãç«¶æããã©ãŒãã³ã¹ãžã®æå¹æ§ãæ¯æãããšããã³ã¹ã匷ãæåã®äžã€ã§ãã
ããããå®éã«äœ¿ããšãã®äžå¿ã¯ãäœmgãæ£è§£ããã§ã¯ãããŸããã
äœçšéã§è©Šããäœæãšå¯äœçšãèšé²ããã奿¥ã«åçŸããã補åãšãããã確èªããããããŠã確èªã§ããæ¡ä»¶ã ããæ¬çªã§åçŸããã
ã«ãã§ã€ã³ã䜿ããªãéžæãå«ããèªåã«åãæ¹æ³ãæºåããŠããããšããç«¶æçŸå Žã§ã®å®è·µã«ã€ãªãããŸãã
æ¬èšäºã¯äžè¬çãªæ å ±æäŸãç®çãšããŠãããåå¥ã®èšºæã»æ²»çãæåæç€ºãç®çãšãããã®ã§ã¯ãããŸãããæªæå¹ŽãåŠåš ã»æä¹³äžãæè¬äžãçŸæ£ã®ãã人ã¯ãèªå·±å€æã§äœ¿çšããå»åž«ãå°éè·ãžçžè«ããŠãã ããã
ãµããªã¡ã³ããå©çšããç«¶æè ã¯ãã¢ã³ãã»ããŒãã³ã°ã®èгç¹ãã第äžè èªèšŒã®æç¡ãšçŸè¡ãããã確èªãã䜿çšã®æçµå€æã¯æ¬äººã®è²¬ä»»ã§è¡ã£ãŠãã ããã第äžè èªèšŒã¯ãªã¹ã¯ãäžããææ®µã§ãããéåãèµ·ããªãããšãä¿èšŒãããã®ã§ã¯ãããŸããã
åèæç®ã»å ¬åŒæ å ±
ISSN exercise & sports nutrition review update: research & recommendationsïŒ2018ïŒ
IOC consensus statement: dietary supplements and the high-performance athleteïŒ2018ïŒ
ãã®ã¢ã«ãŠã³ãã«ã€ããŠ
ç®¡çæ é€å£«ïŒäœè²åŠä¿®å£«ãBãªãŒã°ãSVãªãŒã°çã®ãããã«ããŽãªãŒããæé·æãŸã§ãç«¶æçŸå Žã§ã¹ããŒãæ é€ãµããŒãã«æºãã£ãŠããŸããç ç©¶ãšçŸå Žãã€ãªãæ å ±ãçºä¿¡ããŸãã
